SAN

73.175

+0.18%↑

SRT3

216.15

+0.51%↑

ORNBV.FI

67.2

-1.97%↓

PHMA

95.6

-1.49%↓

DRW3

87.45

-2.67%↓

SAN

73.175

+0.18%↑

SRT3

216.15

+0.51%↑

ORNBV.FI

67.2

-1.97%↓

PHMA

95.6

-1.49%↓

DRW3

87.45

-2.67%↓

SAN

73.175

+0.18%↑

SRT3

216.15

+0.51%↑

ORNBV.FI

67.2

-1.97%↓

PHMA

95.6

-1.49%↓

DRW3

87.45

-2.67%↓

SAN

73.175

+0.18%↑

SRT3

216.15

+0.51%↑

ORNBV.FI

67.2

-1.97%↓

PHMA

95.6

-1.49%↓

DRW3

87.45

-2.67%↓

SAN

73.175

+0.18%↑

SRT3

216.15

+0.51%↑

ORNBV.FI

67.2

-1.97%↓

PHMA

95.6

-1.49%↓

DRW3

87.45

-2.67%↓

Home・Aktien・Vetoquinol SA

Vetoquinol SA

Geschlossen

BrancheGesundheitswesen

77.1 1.31

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

76.5

Max

77.1

Schlüsselkennzahlen
By Trading Economics
Einkommen	25M
Verkäufe	10M 268M
KGV Branchendurchschnitt	14.588 49.8
Dividendenrendite	1.21
Gewinnspanne	9.734
Angestellte	2,497
EBITDA	252M 301M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+48.05% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	1.21% 2.25%

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-57M 878M
Vorheriger Eröffnungskurs	75.79
Vorheriger Schlusskurs	77.1

Nachrichtenstimmung

By Acuity

50%

175 / 346 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

72.6 / 75.1 Unterstützung & Widerstand

Vetoquinol SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Mai 2026, 22:15 UTC

Akquisitionen, Fusionen, Übernahmen

BMO Financial Group to Sell Transportation-, Vendor-Finance Businesses to Stonepeak

11. Mai 2026, 23:46 UTC

Market Talk

Yen Consolidates as Traders Await Bessent's Meetings -- Market Talk

11. Mai 2026, 23:44 UTC

Market Talk

Nikkei May Rise on AI Enthusiasm -- Market Talk

11. Mai 2026, 23:33 UTC

Market Talk

Gold Rises on Possible Position Adjustments -- Market Talk

11. Mai 2026, 22:37 UTC

Market Talk

CSL's Profit, Revenue Downgrade 'Not a Complete Surprise' -- Market Talk

11. Mai 2026, 22:32 UTC

Ergebnisse

Verde Clean Fuels 1Q Loss/Shr 5c >VGAS

11. Mai 2026, 22:02 UTC

Market Talk

Wichtige Nachrichtenereignisse

Stellar Auto Sales Increase in Canada Could Be Tied to Return of EV Incentives -- Market Talk

11. Mai 2026, 21:49 UTC

Ergebnisse

Rigetti Computing Revenue Triples. Why the Quantum Stock Is Falling. -- Barrons.com

11. Mai 2026, 21:42 UTC

Market Talk

Declining Hours Worked Should Keep Bank of Canada Firmly on Hold -- Market Talk

11. Mai 2026, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

Bank of Montreal to Sell Transportation Finance and Vendor Finance Businesses to Stonepeak

11. Mai 2026, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

BMO: Supports Strategy to Elevate Returns and Accelerate Growth, Transaction Accretive to Cap Ratios and ROE >BMO.T

11. Mai 2026, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

BMO: Positions Businesses for Continued Growth in Efficient Cap Structure >BMO.T

11. Mai 2026, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

BMO: To Invest in 19.9% Equity Interest, Enabling Continued Participation in the Businesses' Long-Term Value Creation >BMO.T

11. Mai 2026, 21:31 UTC

Akquisitionen, Fusionen, Übernahmen

BMO: Announces Strategic Sale of Transportation and Vendor Finance Businesses

11. Mai 2026, 21:23 UTC

Akquisitionen, Fusionen, Übernahmen

CSG Systems Sale to NEC Gets CFIUS Clearance

11. Mai 2026, 21:12 UTC

Ergebnisse

Ovintiv: Full-Yr Production Volumes Expected to Avg 620 to 645 MBOE/d, Full-Yr Expected Cap Investment of $2.25B to $2.35B >OVV

11. Mai 2026, 21:12 UTC

Ergebnisse

Ovintiv 1Q Loss/Shr $2.35 >OVV

11. Mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

11. Mai 2026, 20:44 UTC

Ergebnisse

Steris: Board Approves New $1B Shr Repurchase Program >STE

11. Mai 2026, 20:43 UTC

Ergebnisse

Whirlpool Shares Are Still Falling. Last Week's Earnings Might Be Why. -- Barrons.com

11. Mai 2026, 20:32 UTC

Ergebnisse

CleanSpark 2Q Loss/Shr $1.52 >CLSK

11. Mai 2026, 20:32 UTC

Ergebnisse

CleanSpark 2Q Rev $136.4M >CLSK

11. Mai 2026, 20:30 UTC

Ergebnisse

Hims & Hers Stock Sinks. Why Earnings Offered Wall Street a Big Surprise. -- Barrons.com

11. Mai 2026, 20:30 UTC

Ergebnisse

Steris 4Q Cont Ops EPS $2.24 >STE

11. Mai 2026, 20:30 UTC

Ergebnisse

Steris 4Q Rev $1.6B >STE

11. Mai 2026, 20:30 UTC

Ergebnisse

Steris Sees FY Adj EPS $11.10-Adj EPS $11.30 >STE

11. Mai 2026, 20:30 UTC

Ergebnisse

Steris 4Q Adj EPS $2.83 >STE

11. Mai 2026, 20:22 UTC

Heiße Aktien

Stocks to Watch: Moderna, Intel, Micron, Fox -- WSJ

11. Mai 2026, 19:37 UTC

Ergebnisse

More Bad News at KKR's Private Credit Fund -- Barrons.com

11. Mai 2026, 19:32 UTC

Market Talk

Oil Gains As Trump Rejects Iran's Response to U.S. Plan -- Market Talk

Peer-Vergleich

Kursveränderung

Vetoquinol SA Prognose

Kursziel

By TipRanks

48.05% Vorteil

12-Monats-Prognose

Durchschnitt 110 EUR 48.05%

Hoch 110 EUR

Tief 110 EUR

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vetoquinol SA – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vetoquinol SA – Dist abgegeben haben.

Technischer Score

By Trading Central

72.6 / 75.1Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Stimmung

By Acuity

175 / 346 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.